Global Anti-inflammatory Biologics Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Synthetic Type
Biological Type
Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Sun Pharmaceutical Industries Ltd
Sanofi
GlaxoSmithKline

Table of Content
1 Anti-inflammatory Biologics Market Overview
1.1 Product Overview and Scope of Anti-inflammatory Biologics
1.2 Anti-inflammatory Biologics Segment by Type
1.2.1 Global Anti-inflammatory Biologics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Synthetic Type
1.2.3 Biological Type
1.3 Anti-inflammatory Biologics Segment by Application
1.3.1 Anti-inflammatory Biologics Sales Comparison by Application: (2021-2027)
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Global Anti-inflammatory Biologics Market Size Estimates and Forecasts
1.4.1 Global Anti-inflammatory Biologics Revenue 2016-2027
1.4.2 Global Anti-inflammatory Biologics Sales 2016-2027
1.4.3 Anti-inflammatory Biologics Market Size by Region: 2016 Versus 2021 Versus 2027
2 Anti-inflammatory Biologics Market Competition by Manufacturers
2.1 Global Anti-inflammatory Biologics Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anti-inflammatory Biologics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-inflammatory Biologics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-inflammatory Biologics Manufacturing Sites, Area Served, Product Type
2.5 Anti-inflammatory Biologics Market Competitive Situation and Trends
2.5.1 Anti-inflammatory Biologics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-inflammatory Biologics Players Market Share by Revenue
2.5.3 Global Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-inflammatory Biologics Retrospective Market Scenario by Region
3.1 Global Anti-inflammatory Biologics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Anti-inflammatory Biologics Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Anti-inflammatory Biologics Market Facts & Figures by Country
3.3.1 North America Anti-inflammatory Biologics Sales by Country
3.3.2 North America Anti-inflammatory Biologics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-inflammatory Biologics Market Facts & Figures by Country
3.4.1 Europe Anti-inflammatory Biologics Sales by Country
3.4.2 Europe Anti-inflammatory Biologics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-inflammatory Biologics Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-inflammatory Biologics Sales by Region
3.5.2 Asia Pacific Anti-inflammatory Biologics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-inflammatory Biologics Market Facts & Figures by Country
3.6.1 Latin America Anti-inflammatory Biologics Sales by Country
3.6.2 Latin America Anti-inflammatory Biologics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-inflammatory Biologics Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-inflammatory Biologics Sales by Country
3.7.2 Middle East and Africa Anti-inflammatory Biologics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-inflammatory Biologics Historic Market Analysis by Type
4.1 Global Anti-inflammatory Biologics Sales Market Share by Type (2016-2021)
4.2 Global Anti-inflammatory Biologics Revenue Market Share by Type (2016-2021)
4.3 Global Anti-inflammatory Biologics Price by Type (2016-2021)
5 Global Anti-inflammatory Biologics Historic Market Analysis by Application
5.1 Global Anti-inflammatory Biologics Sales Market Share by Application (2016-2021)
5.2 Global Anti-inflammatory Biologics Revenue Market Share by Application (2016-2021)
5.3 Global Anti-inflammatory Biologics Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AbbVie Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Johnson & Johnson Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Amgen Inc
6.3.1 Amgen Inc Corporation Information
6.3.2 Amgen Inc Description and Business Overview
6.3.3 Amgen Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Amgen Inc Product Portfolio
6.3.5 Amgen Inc Recent Developments/Updates
6.4 AstraZeneca PLC
6.4.1 AstraZeneca PLC Corporation Information
6.4.2 AstraZeneca PLC Description and Business Overview
6.4.3 AstraZeneca PLC Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 AstraZeneca PLC Product Portfolio
6.4.5 AstraZeneca PLC Recent Developments/Updates
6.5 Pfizer, Inc
6.5.1 Pfizer, Inc Corporation Information
6.5.2 Pfizer, Inc Description and Business Overview
6.5.3 Pfizer, Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer, Inc Product Portfolio
6.5.5 Pfizer, Inc Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Novartis Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Roche Product Portfolio
6.7.5 Roche Recent Developments/Updates
6.8 Sun Pharmaceutical Industries Ltd
6.8.1 Sun Pharmaceutical Industries Ltd Corporation Information
6.8.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
6.8.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sun Pharmaceutical Industries Ltd Product Portfolio
6.8.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Sanofi Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Corporation Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
6.10.4 GlaxoSmithKline Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
7 Anti-inflammatory Biologics Manufacturing Cost Analysis
7.1 Anti-inflammatory Biologics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-inflammatory Biologics
7.4 Anti-inflammatory Biologics Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-inflammatory Biologics Distributors List
8.3 Anti-inflammatory Biologics Customers
9 Anti-inflammatory Biologics Market Dynamics
9.1 Anti-inflammatory Biologics Industry Trends
9.2 Anti-inflammatory Biologics Growth Drivers
9.3 Anti-inflammatory Biologics Market Challenges
9.4 Anti-inflammatory Biologics Market Restraints
10 Global Market Forecast
10.1 Anti-inflammatory Biologics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-inflammatory Biologics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anti-inflammatory Biologics by Type (2022-2027)
10.2 Anti-inflammatory Biologics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-inflammatory Biologics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anti-inflammatory Biologics by Application (2022-2027)
10.3 Anti-inflammatory Biologics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-inflammatory Biologics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anti-inflammatory Biologics by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer